T

TELA Bio
D

TELA

1.67000
USD
0.00
(0.00%)
Market Closed
Volume
258
EPS
-1
Div Yield
-
P/E
-1
Market Cap
66,056,832
Related Instruments
AMAT
AMAT
-3.450
(-1.99%)
169.490 USD
ASX
ASX
-0.260
(-2.50%)
10.135 USD
COHR
COHR
-1.100
(-1.34%)
81.210 USD
ENTG
ENTG
-0.870
(-1.14%)
75.390 USD
F
FORM
-0.735
(-2.21%)
32.555 USD
I
ICHR
-0.220
(-1.26%)
17.200 USD
KLAC
KLAC
-21.16
(-2.43%)
850.00 USD
K
KLIC
-0.600
(-1.76%)
33.430 USD
LRCX
LRCX
-1.800
(-1.95%)
90.470 USD
M
MKSI
-1.500
(-1.63%)
90.710 USD
SNPS
SNPS
-3.33
(-0.70%)
470.65 USD
TER
TER
-0.004
(-0.00%)
86.290 USD
U
UCTT
-0.440
(-2.16%)
19.940 USD
More
News

Title: TELA Bio

Sector: Healthcare
Industry: Medical Devices
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.